# CRVS (Corvus Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Corvus Pharmaceuticals, Inc. reported $223.9M in total assets and a net loss of $64.31M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CRVS
- Markdown: https://convexityos.com/fundamentals/CRVS.md
- SEC CIK: 0001626971
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001626971&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$67.75M | Operating profit |
| Net Income | FY 2025 | -$64.31M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.70 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$47.94M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $202.9M | Total debt: $632K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $33.72M | $19.39M | $16.53M | $24.47M | $29.11M | $31.83M | $37.98M | $38.59M | $46.30M | $29.36M |
| Total Operating Expenses | $42.97M | $27.55M | $23.41M | $32.56M | $38.63M | $43.76M | $48.85M | $49.22M | $56.52M | $36.98M |
| **Operating Income** | -$42.97M | -$27.55M | -$23.41M | -$32.56M | -$38.63M | -$43.76M | -$48.85M | -$49.22M | -$56.52M | -$36.98M |
| **EBITDA** | -$42.87M | -$27.46M | -$23.26M | -$32.20M | -$38.17M | -$43.13M | -$48.11M | -$48.38M | -$55.68M | -$36.38M |
| Income Before Tax | -$13.32M | -$59.10M | -$21.75M | -$41.31M | -$43.24M | -$6.00M | -$46.67M | -$46.94M | -$55.66M | -$36.38M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$15.28M | -$62.29M | -$27.03M | -$41.31M | -$43.24M | -$6.00M | -$46.67M | -$46.94M | -$55.66M | -$36.38M |
| Basic EPS | -$0.19 | -$1.02 | -$0.56 | -$0.89 | -$1.03 | -$0.20 | -$1.59 | -$1.71 | -$2.72 | -$2.36 |
| **Diluted EPS** | -$0.53 | -$1.02 | -$0.56 | -$0.89 | -$1.03 | -$0.20 | -$1.59 | -$1.71 | -$2.72 | -$2.36 |
| Basic Shares Outstanding | 79.0M | 61.0M | 48.0M | 46.6M | 41.9M | 29.5M | 29.3M | 27.5M | 20.5M | 15.4M |
| Diluted Shares Outstanding | 79.7M | 61.0M | 48.0M | 46.6M | 41.9M | 29.5M | 29.3M | 27.5M | 20.5M | 15.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.78M | $15.96M | $11.18M | $9.94M | $8.45M | $7.87M | $7.45M | $5.97M |
| Total Operating Expenses | $21.36M | $19.30M | $14.88M | $12.22M | $10.57M | $10.26M | $9.92M | $8.11M |
| **Operating Income** | -$21.36M | -$19.30M | -$14.88M | -$12.22M | -$10.57M | -$10.26M | -$9.92M | -$8.11M |
| **EBITDA** | -$21.27M | -$19.26M | -$14.85M | -$12.19M | -$10.54M | -$10.23M | -$9.90M | -$8.09M |
| Income Before Tax | -$19.45M | -$17.25M | -$13.09M | -$11.61M | -$9.83M | -$7.61M | $15.73M | -$9.94M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$20.34M | -$17.96M | -$13.69M | -$12.32M | -$10.16M | -$8.00M | $15.19M | -$12.11M |
| Basic EPS | -$0.22 | -$0.19 | -$0.15 | -- | -$0.12 | -$0.10 | $0.21 | -- |
| **Diluted EPS** | -$0.22 | -$0.19 | -$0.15 | -- | -$0.12 | -$0.10 | -$0.13 | -- |
| Basic Shares Outstanding | 92.5M | 92.4M | 90.0M | -- | 82.8M | 77.8M | 72.1M | -- |
| Diluted Shares Outstanding | 92.5M | 92.4M | 90.0M | -- | 82.8M | 77.8M | 75.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.58M | $8.74M | $12.62M | $13.16M | $63.46M | $16.45M | $5.15M | $39.20M | $45.11M | $5.05M |
| Short-Term Investments | $52.17M | $43.22M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $56.80M | $52.00M | $27.10M | $42.30M | $69.50M | $44.30M | $78.00M | $114.6M | $90.10M | $134.9M |
| Accounts Receivable, Net | $37K | $75K | $26K | $588K | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $353K | $548K | $220K | $102K | $128K | $406K | $486K | $265K | $412K | $772K |
| **Total Current Assets** | $58.21M | $54.41M | $27.96M | $43.66M | $71.31M | $45.34M | $79.34M | $115.6M | $91.23M | $136.0M |
| Property, Plant & Equipment, Net | $220K | $151K | $236K | $353K | $451K | $906K | $1.46M | $2.18M | $2.67M | $3.25M |
| Other Non-Current Assets | $855K | $632K | $89K | $129K | $236K | $414K | $513K | $463K | $869K | $869K |
| **Total Non-Current Assets** | $12.90M | $14.50M | $17.60M | $24.58M | $38.14M | $40.19M | $4.30M | $2.64M | $3.54M | $4.12M |
| **Total Assets** | $71.12M | $68.91M | $45.55M | $68.24M | $109.5M | $85.53M | $83.65M | $118.2M | $94.78M | $140.2M |
| Accounts Payable | $2.49M | $2.58M | $1.52M | $1.98M | $1.56M | $3.47M | $2.45M | $2.00M | $3.45M | $1.90M |
| **Total Current Liabilities** | $9.38M | $35.40M | $6.87M | $10.75M | $9.69M | $12.15M | $10.22M | $7.03M | $8.97M | $5.94M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $869K | $971K | $1.41M |
| **Total Non-Current Liabilities** | $534K | $937K | $0 | $1.37M | $2.60M | $1.23M | $2.31M | $869K | $971K | $1.41M |
| **Total Liabilities** | $9.91M | $36.34M | $6.87M | $12.12M | $12.29M | $13.38M | $12.54M | $7.90M | $9.94M | $7.35M |
| **Total Debt (incl. Leases)** | $937K | $1.12M | $1.37M | $2.60M | $3.65M | $2.31M | $3.19M | -- | -- | -- |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K |
| Retained Earnings | -$412.3M | -$397.0M | -$334.7M | -$307.7M | -$266.4M | -$223.1M | -$217.1M | -$170.5M | -$123.5M | -$67.87M |
| Accumulated Other Comp. Income | -$896K | -$1.29M | -$967K | -$563K | $1.87M | $4.0K | $29K | -$34K | -$41K | -$39K |
| **Total Stockholders' Equity** | $61.20M | $32.57M | $38.68M | $56.12M | $97.16M | $72.15M | $71.11M | $110.3M | $84.83M | $132.8M |
| Total Equity | $61.20M | $32.57M | $38.68M | $56.12M | $97.16M | $72.15M | $71.11M | $110.3M | $84.83M | $132.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15.01M | $18.91M | $40.10M | $4.58M | $2.87M | $14.69M | $5.00M | $8.74M |
| Short-Term Investments | $187.9M | $196.3M | $196.6M | $52.17M | -- | -- | -- | $43.22M |
| **Cash & Short-Term Investments** | $202.9M | $215.2M | $236.7M | $56.80M | $65.70M | $74.40M | $44.20M | $52.00M |
| Accounts Receivable, Net | $5.0K | $6.0K | $43K | $37K | $32K | $86K | $79K | $75K |
| Other Current Assets | $317K | $575K | $367K | $353K | $509K | $569K | $458K | $548K |
| **Total Current Assets** | $206.3M | $221.0M | $239.9M | $58.21M | $66.94M | $75.78M | $45.49M | $54.41M |
| Property, Plant & Equipment, Net | $801K | $830K | $282K | $220K | $221K | $249K | $165K | $151K |
| Other Non-Current Assets | $1.70M | $1.71M | $1.72M | $855K | $852K | $626K | $629K | $632K |
| **Total Non-Current Assets** | $17.53M | $18.31M | $13.25M | $12.90M | $13.53M | $13.68M | $13.95M | $14.50M |
| **Total Assets** | $223.9M | $239.3M | $253.2M | $71.12M | $80.47M | $89.46M | $59.44M | $68.91M |
| Accounts Payable | $5.65M | $4.05M | $4.70M | $2.49M | $1.97M | $3.14M | $1.31M | $2.58M |
| **Total Current Liabilities** | $15.42M | $13.67M | $12.11M | $9.38M | $8.07M | $8.51M | $9.28M | $35.40M |
| **Total Non-Current Liabilities** | $139K | $274K | $406K | $534K | $632K | $728K | $834K | $937K |
| **Total Liabilities** | $15.56M | $13.95M | $12.52M | $9.91M | $8.71M | $9.23M | $10.11M | $36.34M |
| **Total Debt (incl. Leases)** | $632K | $728K | $834K | $937K | $1.01M | $1.08M | $1.15M | $1.12M |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$464.3M | -$443.9M | -$426.0M | -$412.3M | -$400.0M | -$389.8M | -$381.8M | -$397.0M |
| Accumulated Other Comp. Income | -$1.59M | -$1.29M | -$1.13M | -$896K | -$1.06M | -$1.15M | -$1.25M | -$1.29M |
| **Total Stockholders' Equity** | $208.3M | $225.3M | $240.7M | $61.20M | $71.77M | $80.23M | $49.33M | $32.57M |
| Total Equity | $208.3M | $225.3M | $240.7M | $61.20M | $71.77M | $80.23M | $49.33M | $32.57M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.28M | -$62.29M | -$27.03M | -$41.31M | -$43.24M | -$6.00M | -$46.67M | -$46.94M | -$55.66M | -$36.38M |
| Depreciation & Amortization | $105K | $85K | $151K | $367K | $460K | $632K | $743K | $847K | $842K | $594K |
| Stock-Based Compensation | $5.33M | $3.00M | $2.15M | $2.69M | $4.23M | $5.75M | $7.35M | $7.13M | $6.23M | $3.83M |
| Change in Payables | -$91K | $1.06M | -$451K | $411K | -$1.90M | $1.02M | $450K | -$1.46M | $1.55M | $518K |
| **Operating Cash Flow** | -$32.80M | -$25.42M | -$23.93M | -$27.02M | -$36.72M | -$34.78M | -$37.32M | -$40.99M | -$46.21M | -$27.86M |
| Capital Expenditure | -$174K | -- | -$34K | -$269K | -$5.0K | -$76K | -$25K | -$355K | -$266K | -$2.20M |
| **Free Cash Flow** | -$32.97M | -- | -$23.97M | -$27.29M | -$36.72M | -$34.85M | -$37.35M | -$41.34M | -$46.48M | -$30.06M |
| Purchases of Investments | -$91.75M | -$70.12M | -$47.05M | -$66.19M | -$9.36M | -$42.54M | -$138.6M | -$161.9M | -$88.31M | -$258.3M |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | $87.39M | -- | -- | -- | $217.9M |
| **Investing Cash Flow** | -$7.80M | -$27.48M | $15.54M | -$23.28M | $21.56M | $44.77M | $3.25M | -$30.19M | $84.83M | -$42.56M |
| Common Stock Issued | -- | $16.41M | -- | -- | $31.99M | -- | -- | $64.88M | $711K | $71.35M |
| **Financing Cash Flow** | $36.43M | $49.03M | $7.86M | $0 | $62.16M | $1.31M | $24K | $65.27M | $1.44M | $71.36M |
| **Net Change in Cash** | -$4.16M | -$3.88M | -$539K | -$50.30M | $47.00M | $11.30M | -$34.04M | -$5.91M | $40.06M | $945K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$20.34M | -$17.96M | -$13.69M | -$12.32M | -$10.16M | -$8.00M | $15.19M | -$12.11M |
| Depreciation & Amortization | $95K | $34K | $29K | $26K | $28K | $29K | $22K | $20K |
| Stock-Based Compensation | $2.83M | $2.61M | $2.65M | $1.57M | $1.25M | $1.26M | $1.25M | $813K |
| Change in Payables | $1.60M | -$650K | $2.21M | $517K | -$1.16M | $1.83M | -$1.27M | $709K |
| **Operating Cash Flow** | -$12.21M | -$15.40M | -$10.37M | -$9.19M | -$9.57M | -$5.78M | -$8.26M | -$8.46M |
| Capital Expenditure | -$66K | -$582K | -$91K | -$25K | $0 | -$113K | -$36K | -- |
| **Free Cash Flow** | -$12.28M | -$15.98M | -$10.46M | -$9.22M | -$9.57M | -$5.89M | -$8.30M | -- |
| Purchases of Investments | -$30.38M | -$47.74M | -$161.7M | -$13.42M | -$31.15M | -$39.48M | -$7.71M | -$20.36M |
| **Investing Cash Flow** | $7.52M | -$5.96M | -$144.8M | $10.88M | -$2.62M | -$20.30M | $4.24M | -$6.08M |
| Common Stock Issued | $0 | $0 | $189.4M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $805K | $166K | $190.7M | $20K | $360K | $35.77M | $279K | -- |
| **Net Change in Cash** | -$3.89M | -$21.20M | $35.53M | $1.71M | -$11.82M | $9.69M | -$3.74M | $4.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -25.0% | -191.3% | -69.9% | -73.6% | -44.5% | -8.3% | -65.6% | -42.5% | -65.6% | -27.4% |
| Return on Assets (ROA) | -21.5% | -90.4% | -59.3% | -60.5% | -39.5% | -7.0% | -55.8% | -39.7% | -58.7% | -26.0% |
| Current Ratio | 6.21x | 1.54x | 4.07x | 4.06x | 7.36x | 3.73x | 7.76x | 16.45x | 10.17x | 22.89x |
| Quick Ratio | 6.06x | 1.47x | 3.95x | 3.99x | 7.17x | 3.65x | 7.63x | 16.31x | 10.05x | 22.70x |
| Debt to Equity | 0.02x | 0.03x | 0.04x | 0.05x | 0.04x | 0.03x | 0.04x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -30.9% | -24.0% | -18.4% | -25.0% | -21.0% | -56.3% | -83.9% | -191.3% |
| Return on Assets (ROA) | -28.7% | -22.6% | -17.4% | -21.5% | -18.7% | -50.5% | -69.7% | -90.4% |
| Current Ratio | 13.38x | 16.16x | 19.81x | 6.21x | 8.29x | 8.91x | 4.90x | 1.54x |
| Quick Ratio | 13.16x | 15.74x | 19.55x | 6.06x | 8.14x | 8.76x | 4.77x | 1.47x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.02x | 0.01x | 0.01x | 0.02x | 0.03x |
| **Net Income Growth (YoY)** | -- | -- | -190.1% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -171.4% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
